| The role of the hospital environment in the healthcare-associated infections: a general review of the literature. A Facciolà, GF Pellicano, G Visalli, IA Paolucci, E VENANZI RULLO, ... European Review for Medical & Pharmacological Sciences 23 (3), 2019 | 126 | 2019 |
| Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre Italian study M Berretta, L Rinaldi, R Taibi, P Tralongo, A Fulvi, V Montesarchio, ... Frontiers in oncology 10, 594, 2020 | 74 | 2020 |
| Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students G Visalli, B Cosenza, F Mazzù, MP Bertuccio, P Spataro, GF Pellicanò, ... Journal of preventive medicine and hygiene 60 (2), E84, 2019 | 74 | 2019 |
| HIV‐associated psoriasis: epidemiology, pathogenesis, and management M Ceccarelli, E Venanzi Rullo, M Vaccaro, A Facciolà, F d'Aleo, ... Dermatologic Therapy 32 (2), e12806, 2019 | 74 | 2019 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 69 | 2019 |
| The new era of vaccines: the" nanovaccinology". A Facciolà, G Visalli, P Laganà, V La Fauci, R Squeri, GF Pellicanò, ... European Review for Medical & Pharmacological Sciences 23 (16), 2019 | 65 | 2019 |
| Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'aleo, M Di Rosa, ... Eur Rev Med Pharmacol Sci 21 (24), 5868-5869, 2017 | 64 | 2017 |
| Factors associated with weight gain in people treated with dolutegravir L Taramasso, P Bonfanti, E Ricci, G Orofino, N Squillace, B Menzaghi, ... Open Forum Infectious Diseases 7 (6), ofaa195, 2020 | 61 | 2020 |
| Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives A Facciolà, G Visalli, S La Maestra, M Ceccarelli, F D’Aleo, G Nunnari, ... Environmental Toxicology and Pharmacology 65, 23-30, 2019 | 61 | 2019 |
| Transmission mode associated with coronavirus disease 2019: a review. F Vella, P Senia, M Ceccarelli, E Vitale, H Maltezou, R Taibi, A Lleshi, ... European Review for Medical & Pharmacological Sciences 24 (14), 2020 | 60 | 2020 |
| Malignant melanoma in HIV: Epidemiology, pathogenesis, and management A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'Andrea, M Coco, C Micali, ... Dermatologic Therapy 33 (1), e13180, 2020 | 41 | 2020 |
| Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors EV Rullo, M Ceccarelli, F Condorelli, A Facciolà, G Visalli, F D'Aleo, ... Molecular Medicine Reports 19 (3), 1987-1995, 2019 | 40 | 2019 |
| Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review M Ceccarelli, EV Rullo, A Facciolà, G Madeddu, B Cacopardo, R Taibi, ... Oncotarget 9 (24), 17171, 2018 | 36 | 2018 |
| High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study BM Celesia, L Nigro, MR Pinzone, C Coco, R La Rosa, F Bisicchia, ... Eur Rev Med Pharmacol Sci 17 (15), 2040-2046, 2013 | 36 | 2013 |
| The effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on liver enzymes, glucose, and lipid profile N Squillace, E Ricci, B Menzaghi, GV De Socio, S Passerini, C Martinelli, ... Drug Design, Development and Therapy, 5515-5520, 2020 | 33 | 2020 |
| Non-AIDS defining cancers: a comprehensive update on diagnosis and management. M Ceccarelli, EV Rullo, MA Marino, F d'Aleo, GF Pellicanò, F D'ANDREA, ... European Review for Medical & Pharmacological Sciences 24 (7), 2020 | 33 | 2020 |
| Efficacy and safety of boosted and unboosted atazanavir‐containing antiretroviral regimens in real life: results from a multicentre cohort study R Giuntini, C Martinelli, E Ricci, F Vichi, E Gianelli, G Madeddu, C Abeli, ... HIV medicine 11 (1), 40-45, 2010 | 31 | 2010 |
| Expression of the OAS gene family is highly modulated in subjects affected by juvenile dermatomyositis, resembling an immune response to a dsRNA virus infection G Musumeci, P Castrogiovanni, I Barbagallo, D Tibullo, C Sanfilippo, ... International journal of molecular sciences 19 (9), 2786, 2018 | 29 | 2018 |
| New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection M Ceccarelli, E Venanzi Rullo, M Berretta, B Cacopardo, GF Pellicanò, ... Dermatologic Therapy 34 (1), e14660, 2021 | 27 | 2021 |
| Durability of dolutegravir-based regimens: a 5-year prospective observational study L Taramasso, A De Vito, ED Ricci, G Orofino, N Squillace, B Menzaghi, ... AIDS Patient Care and STDs 35 (9), 342-353, 2021 | 24 | 2021 |
Emmanuele Venanzi RulloUniversità di messinaVerified email at unime.it